Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Will a Stock Split Help Rally These 2 Underperforming Nasdaq Stocks?
10:15am, Wednesday, 08'th Jun 2022
Both of these stocks are down by more than 19% this year.
DexCom (DXCM) to Boost Diabetes Management With New Coverage
12:49pm, Thursday, 02'nd Jun 2022
DexCom's (DXCM) G6 CGM System gets public coverage through Prince Edward Island's Diabetes Glucose Sensor Program, which can aid in effective diabetes management.
2 of the Nasdaq's Best Long-Term Buys Right Now
10:15am, Thursday, 02'nd Jun 2022
You can buy and forget about these stocks.
Why DexCom Stock Is Jumping Today
11:12am, Tuesday, 31'st May 2022
The company confirmed that it isn't in merger discussions with Insulet.
DexCom stock leads S&P 500's premarket gainers after denying merger talks, and Insulet stock drops
09:26am, Tuesday, 31'st May 2022
Shares of DexCom Inc. DXCM, +5.35% surged 8.1% to pace the S&P 500's SPX, -0.37% premarket gainers, after the diabetes care company said it was not currently in "active discussions" regarding a merger
What Makes DexCom Stock A Better Pick Over This Insulin Pump Maker?
06:00am, Friday, 27'th May 2022
We believe that this gap in the valuation of these two companies does not make sense, given that DexCom has demonstrated better revenue growth and profitability than Insulet.
Why DexCom Is Down More Than 11% on Tuesday
12:56pm, Tuesday, 24'th May 2022
Whispers of an acquisition aren't being well received by already nervous shareholders, who may be questioning the timing as well as the potential of such a deal.
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
10:52am, Tuesday, 24'th May 2022
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company. The post PODD Stock Pops 7% as DexCom Considers Insulet Corpora
Insulet Stock Rises on Report of Dexcom Acquisition Talks
06:29am, Tuesday, 24'th May 2022
A potential deal could be announced in coming weeks, according to a Bloomberg report.
Dexcom Announces Upcoming Conference Presentation
08:00am, Monday, 23'rd May 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
12:02pm, Thursday, 19'th May 2022
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
DexCom (DXCM) Q1 Earnings Miss, Revenues Beat Estimates
08:17am, Friday, 29'th Apr 2022
Despite a decline in bottom line, DexCom's (DXCM) first-quarter results benefit from domestic and international revenue growth and solid new customer additions.
Is DexCom Stock a Buy Now?
06:45am, Friday, 29'th Apr 2022
The diabetes market is full of growth potential.
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q1 2022 Results - Earnings Call Transcript
09:24pm, Thursday, 28'th Apr 2022
DexCom, Inc. (NASDAQ:DXCM ) Q1 2022 Earnings Conference Call April 28, 2022 5:30 PM ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and Chief Executive
DexCom (DXCM) Misses Q1 Earnings Estimates
07:35pm, Thursday, 28'th Apr 2022
DexCom (DXCM) delivered earnings and revenue surprises of -36% and 1.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
